Health & Safety Trouble for ecstasy? What MDMA’s FDA setback could mean for psychedelics 8:12am June 13, 2024 by Will Stone Psychedelics researchers and investors are still reeling from last week’s no vote for MDMA by a panel of advisers to the FDA.
Health & Safety As the FDA evaluates ecstasy treatment for PTSD, questions mount about the evidence 4:30pm May 13, 2024 by Will Stone Clinical trials of MDMA have been promising, but concerns have emerged about the quality of the research. A June hearing scheduled by the Food and Drug Administration is likely to address them.